The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks

por De Giglio, Andrea, Ricciuti, Biagio, Metro, Giulio
Publicado 2023

Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients

por De Giglio, Andrea, Deiana, Chiara, Di Federico, Alessandro
Publicado 2022

Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer

por De Giglio, Andrea, Di Federico, Alessandro, Metro, Giulio
Publicado 2022

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

por Ricciuti, Biagio, Baglivo, Sara, De Giglio, Andrea, Chiari, Rita
Publicado 2018

Carboplatin, nab-paclitaxel plus atezolizumab in IMpower 130 trial: new weapons beyond controversies

por De Giglio, Andrea, Nuvola, Giacomo, Dall’Olio, Filippo Gustavo
Publicado 2019

The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)

por De Giglio, Andrea, Di Federico, Alessandro, Nuvola, Giacomo, Deiana, Chiara, Gelsomino, Francesco
Publicado 2021

Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Revi...

por Di Federico, Alessandro, De Giglio, Andrea, Parisi, Claudia, Gelsomino, Francesco, Boni, Luca, Ardizzoni, Andrea
Publicado 2021

Advanced non-small-cell lung cancer: how to manage non-oncogene disease

por De Giglio, Andrea, Di Federico, Alessandro, Deiana, Chiara, Ricciuti, Biagio, Brambilla, Marta, Metro, Giulio
Publicado 2022

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

por Raschi, Emanuel, Rossi, Simone, De Giglio, Andrea, Fusaroli, Michele, Burgazzi, Flavio, Rinaldi, Rita, Potena, Luciano
Publicado 2023

Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting S...

por Sisi, Monia, Fusaroli, Michele, De Giglio, Andrea, Facchinetti, Francesco, Ardizzoni, Andrea, Raschi, Emanuel, Gelsomino, Francesco
Publicado 2022

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors

por Tateo, Valentina, Manuzzi, Lisa, De Giglio, Andrea, Parisi, Claudia, Lamberti, Giuseppe, Campana, Davide, Pantaleo, Maria Abbondanza
Publicado 2020

An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances

por Tateo, Valentina, Manuzzi, Lisa, Parisi, Claudia, De Giglio, Andrea, Campana, Davide, Pantaleo, Maria Abbondanza, Lamberti, Giuseppe
Publicado 2021

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)

por De Giglio, Andrea, Aprile, Marta, Di Federico, Alessandro, Sperandi, Francesca, Melotti, Barbara, Gelsomino, Francesco, Ardizzoni, Andrea
Publicado 2022

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

por Ricciuti, Biagio, Baglivo, Sara, Paglialunga, Luca, De Giglio, Andrea, Bellezza, Guido, Chiari, Rita, Crinò, Lucio, Metro, Giulio
Publicado 2017

EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature

por Di Federico, Alessandro, Filetti, Marco, Palladini, Arianna, Giusti, Raffaele, Piras, Marta, De Giglio, Andrea, Ardizzoni, Andrea, Gelsomino, Francesco
Publicado 2022

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review

por Nigro, Maria Concetta, Marchese, Paola Valeria, Deiana, Chiara, Casadio, Chiara, Galvani, Linda, Di Federico, Alessandro, De Giglio, Andrea
Publicado 2023

Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes

por Di Federico, Alessandro, De Giglio, Andrea, Gelsomino, Francesco, De Biase, Dario, Giunchi, Francesca, Palladini, Arianna, Sperandi, Francesca, Melotti, Barbara, Ardizzoni, Andrea
Publicado 2022

Hybrid Polyelectrolyte Nanocomplexes for Non-Viral Gene Delivery with Favorable Efficacy and Safety Profile

por Maiorano, Gabriele, Guido, Clara, Russo, Annamaria, Giglio, Andrea, Rizzello, Loris, Testini, Mariangela, Cortese, Barbara, D’Amone, Stefania, Gigli, Giuseppe, Palamà, Ilaria Elena
Publicado 2022

The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy

por De Giglio, Andrea, Tassinari, Elisa, Zappi, Arianna, Di Federico, Alessandro, Lenzi, Barbara, Sperandi, Francesca, Melotti, Barbara, Gelsomino, Francesco, Maltoni, Marco, Ardizzoni, Andrea
Publicado 2022

How to manage KRAS G12C-mutated advanced non-small-cell lung cancer

por Ricciuti, Biagio, Mira, Alessia, Andrini, Elisa, Scaparone, Pietro, Michelina, Sandra Vietti, Pecci, Federica, Cantini, Luca, De Giglio, Andrea, Lamberti, Giuseppe, Ambrogio, Chiara, Metro, Giulio
Publicado 2022